Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Novo Nordisk Stock a Screaming Buy Right Now?


Danish drugmaker Novo Nordisk (NYSE: NVO) has been on an epic bull run ever since the Food and Drug Administration (FDA) approved its weight-loss medication, Wegovy, in the summer of 2021. The pharmaceutical giant's shares have more than doubled in value over this period, while the broader markets have struggled due to a confluence of geopolitical headwinds, the lingering impacts of the pandemic, and rising interest rates.

NVO Chart

NVO data by YCharts.

Continue reading


Source Fool.com

Like: 0
NVO
Share

Comments